Barclays Maintains Pfizer(PFE.US) With Sell Rating, Maintains Target Price $25

Barclays Maintains Pfizer(PFE.US) With Sell Rating, Maintains Target Price $25  Moomoo

Summary aggregated from Moomoo's public RSS feed. The full reporting belongs to Moomoo — please read it on their site.